cover
Contact Name
Dikki Miswanda
Contact Email
editorial.ijsp@gmail.com
Phone
+6281361821460
Journal Mail Official
editorial.ijsp@gmail.com
Editorial Address
Jl. Balai Desa No.10-16G, Kota Medan, Sumatera Utara 20148
Location
Kota medan,
Sumatera utara
INDONESIA
Indonesian Journal of Science and Pharmacy
ISSN : -     EISSN : 30255244     DOI : -
Core Subject : Health, Science,
Indonesian Journal of Science and Pharmacy (IJSP) accepts scientific articles as original research articles, short communication, reviews, and mini-reviews from anyone without any discrimination, as long as they submit articles that meet scientific principles. Indonesian Journal of Science and Pharmacy publishes various scientific articles covering Science and Pharmacy, Pharmaceutical Sciences. The following are the field within the scope of Indonesian Journal of Science and Pharmacy: Chemistry, Biology, Pharmacology-Toxicology, Pharmacognosy-Phytochemistry, Pharmaceuticals, Analytical Pharmacy-Medicinal Chemistry, Natural Product Development, Management Pharmacy, Clinical-Community Pharmacy, Microbiology Pharmacy.
Articles 61 Documents
Anti-Inflammatory Potential of Cyanobacterial Secondary Metabolites: An In Silico Study Targeting COX-1 and COX-2 Michael Kurniawan; Ernestine Arianditha Pranasti
Indonesian Journal of Science and Pharmacy Vol. 4 No. 1 (2026): Indonesian Journal of Science and Pharmacy
Publisher : Pustaka Media Publishing

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.63763/ijsp.v4i1.238

Abstract

Inflammation, pain, and fever are physiological responses commonly managed with nonsteroidal anti-inflammatory drugs (NSAIDs), which act by inhibiting cyclooxygenase (COX). Cyanobacteria are a rich source of structurally diverse secondary metabolites with reported pharmacological activity, yet their potential as COX inhibitors has been little explored computationally. This study evaluated cyanobacterial secondary metabolites as candidate COX-1 and COX-2 inhibitors through an integrated in silico workflow combining Lipinski screening, molecular docking, residue interaction analysis, and ADMET prediction. Of 707 metabolites retrieved from the Comprehensive Marine Natural Products Database, 153 satisfied Lipinski's rule of five and were docked against COX-1 (PDB 4O1Z) and COX-2 (PDB 5IKR) using AutoDock Vina. Re-docking reproduced the co-crystallised ligand poses with root mean square deviation values of 1.04 Å for COX-1 and 1.87 Å for COX-2, confirming that the docking parameters were valid. The metabolites showed binding affinities comparable to several positive controls for COX-1 but lower than the reference inhibitors for COX-2. On the combined basis of binding affinity, binding pose, residue interactions, and ADMET, kalkipyrone, ypaoamide C, and dehydroabietic acid were prioritised as candidates. Kalkipyrone reproduced the catalytic Ser530 hydrogen bond within COX-2, and all three complied with Lipinski's rule of five and showed predicted profiles compatible with oral administration. These findings are computational predictions and require confirmation through molecular dynamics simulation and in vitro and in vivo assays.